Navigating fertility treatments can be a physically and emotionally demanding experience for women. As the sole child bearers, women are more directly impacted by procedures like in vitro fertilization (IVF), which require a significant toll on their bodies even before pregnancy begins. The initial stages often involve 2-4 weeks of fertility hormone treatments, frequently administered through multiple self-injections. Recognizing the stress associated with this process, RQM+ is dedicated to helping bring innovative solutions to market that can ease this burden.
RQM+ is a Pennsylvania-based CRO that provides services such as clinical trials, polymer investigation, billing and strategy development for the medical industry.